Curevac Nv Stock Performance
| CVAC Stock | USD 4.66 0.00 0.00% |
The firm shows a Beta (market volatility) of -0.55, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning CureVac NV are expected to decrease at a much lower rate. During the bear market, CureVac NV is likely to outperform the market. At this point, CureVac NV has a negative expected return of -0.26%. Please make sure to confirm CureVac NV's total risk alpha, kurtosis, relative strength index, as well as the relationship between the potential upside and day median price , to decide if CureVac NV performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days CureVac NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in March 2026. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
Actual Historical Performance (%)
Year To Date Return (0.21) | Ten Year Return (91.66) | All Time Return (91.66) |
| Begin Period Cash Flow | 402.5 M | |
| Total Cashflows From Investing Activities | -18.4 M |
CureVac NV Relative Risk vs. Return Landscape
If you would invest 534.00 in CureVac NV on November 2, 2025 and sell it today you would lose (68.00) from holding CureVac NV or give up 12.73% of portfolio value over 90 days. CureVac NV is currently does not generate positive expected returns and assumes 2.8399% risk (volatility on return distribution) over the 90 days horizon. In different words, 25% of stocks are less volatile than CureVac, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
CureVac NV Target Price Odds to finish over Current Price
The tendency of CureVac Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 4.66 | 90 days | 4.66 | about 87.04 |
Based on a normal probability distribution, the odds of CureVac NV to move above the current price in 90 days from now is about 87.04 (This CureVac NV probability density function shows the probability of CureVac Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days CureVac NV has a beta of -0.55 suggesting as returns on the benchmark increase, returns on holding CureVac NV are expected to decrease at a much lower rate. During a bear market, however, CureVac NV is likely to outperform the market. Additionally CureVac NV has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. CureVac NV Price Density |
| Price |
Predictive Modules for CureVac NV
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as CureVac NV. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.CureVac NV Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. CureVac NV is not an exception. The market had few large corrections towards the CureVac NV's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold CureVac NV, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of CureVac NV within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.17 | |
β | Beta against Dow Jones | -0.55 | |
σ | Overall volatility | 0.39 | |
Ir | Information ratio | -0.11 |
CureVac NV Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of CureVac NV for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for CureVac NV can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| CureVac NV is not yet fully synchronised with the market data | |
| CureVac NV generated a negative expected return over the last 90 days | |
| CureVac NV is unlikely to experience financial distress in the next 2 years | |
| CureVac NV has a strong financial position based on the latest SEC filings |
CureVac NV Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of CureVac Stock often depends not only on the future outlook of the current and potential CureVac NV's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. CureVac NV's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 225.3 M | |
| Cash And Short Term Investments | 485.4 M |
CureVac NV Fundamentals Growth
CureVac Stock prices reflect investors' perceptions of the future prospects and financial health of CureVac NV, and CureVac NV fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CureVac Stock performance.
| Return On Equity | 0.4 | ||||
| Return On Asset | 0.24 | ||||
| Profit Margin | 1.82 % | ||||
| Operating Margin | 5.73 % | ||||
| Current Valuation | 599.28 M | ||||
| Shares Outstanding | 225.17 M | ||||
| Price To Book | 1.03 X | ||||
| Price To Sales | 14.83 X | ||||
| Revenue | 535.18 M | ||||
| Gross Profit | 65.99 M | ||||
| EBITDA | 209.69 M | ||||
| Net Income | 190.88 M | ||||
| Cash And Equivalents | 540.87 M | ||||
| Cash Per Share | 2.85 X | ||||
| Total Debt | 38.97 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 3.61 X | ||||
| Book Value Per Share | 5.63 X | ||||
| Cash Flow From Operations | 101.85 M | ||||
| Earnings Per Share | 0.67 X | ||||
| Market Capitalization | 1.05 B | ||||
| Total Asset | 802.83 M | ||||
| Retained Earnings | (1.4 B) | ||||
| Working Capital | 454.07 M | ||||
About CureVac NV Performance
By analyzing CureVac NV's fundamental ratios, stakeholders can gain valuable insights into CureVac NV's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CureVac NV has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CureVac NV has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 2.15 | 2.04 | |
| Return On Tangible Assets | 0.19 | 0.20 | |
| Return On Capital Employed | 0.22 | 0.23 | |
| Return On Assets | 0.18 | 0.19 | |
| Return On Equity | 0.21 | 0.22 |
Things to note about CureVac NV performance evaluation
Checking the ongoing alerts about CureVac NV for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CureVac NV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CureVac NV is not yet fully synchronised with the market data | |
| CureVac NV generated a negative expected return over the last 90 days | |
| CureVac NV is unlikely to experience financial distress in the next 2 years | |
| CureVac NV has a strong financial position based on the latest SEC filings |
- Analyzing CureVac NV's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CureVac NV's stock is overvalued or undervalued compared to its peers.
- Examining CureVac NV's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CureVac NV's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CureVac NV's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CureVac NV's stock. These opinions can provide insight into CureVac NV's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CureVac Stock analysis
When running CureVac NV's price analysis, check to measure CureVac NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CureVac NV is operating at the current time. Most of CureVac NV's value examination focuses on studying past and present price action to predict the probability of CureVac NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CureVac NV's price. Additionally, you may evaluate how the addition of CureVac NV to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stocks Directory Find actively traded stocks across global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |